SCHEMBL23266258

SCHEMBL23266258

CC(C)Oc1ccc(CCCCO)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.51
CYP4A11 Q02928 3/20 0.49
CYP4F2 P78329 2/20 0.49
KDM4E B2RXH2 1/20 0.48
CYP1A2 P05177 1/20 0.46
GAA P10253 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
ACACB O00763 2/20 0.46
PPARA Q07869 1/20 0.45
LTA4H P09960 1/20 0.45
EPHX2 P34913 1/20 0.45
ALDH1A1 P00352 2/20 0.44
LMNA P02545 2/20 0.44
CA2 P00918 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9027085 0.98 POLB (0.50) POLBCYP4A11CYP4F2KDM4ECYP1A2
SCHEMBL9112221 0.98 POLB (0.50) POLBCYP4A11CYP4F2KDM4ECYP1A2
SCHEMBL5355098 0.94 POLB (0.53) POLBCYP4A11CYP4F2KDM4ECYP1A2
SCHEMBL11683841 0.93 POLB (0.51) POLBCYP4A11CYP4F2KDM4ECYP1A2
SCHEMBL833204 0.86 POLB (0.56) POLBCYP4A11CYP4F2KDM4ECYP1A2
SCHEMBL4523904 0.85 LTA4H (0.67) POLBKDM4EACACBPPARALTA4H
SCHEMBL19058769 0.81 ESR1 (0.53) POLBKDM4EPPARAALDH1A1LMNA
SCHEMBL3033627 0.81 POLB (0.47) POLBKDM4ECYP1A2GAACYP2D6
SCHEMBL8734047 0.81 ESR1 (0.53) POLBKDM4EPPARAALDH1A1LMNA
SCHEMBL26939981 0.81 ESR1 (0.53) POLBKDM4EPPARAALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398168-B2 Preparation method of a glycoside compound SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED (CN) 2025-08-26 US disclosed
US-20220380399-A1 PREPARATION METHOD OF A GLYCOSIDE COMPOUND SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED (CN) 2022-12-01 US disclosed
US-11325937-B2 Glycoside compound and preparation method therefor, composition, application, and intermediate SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED (CN) 2022-05-10 US disclosed
EP-3819303-A1 GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE Shanghai Hutchison Pharmaceuticals Limited (CN) 2021-05-12 EP disclosed
US-20210115082-A1 GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED (CN) 2021-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12398168-B2 Preparation method of a glycoside compound GALE, ST6GAL1, MGAM POLB 3506/4885CYP4A11 81/4885CYP4F2 442/4885
US-20220380399-A1 PREPARATION METHOD OF A GLYCOSIDE COMPOUND GALE, ST6GAL1, MGAM POLB 3506/4885CYP4A11 81/4885CYP4F2 442/4885
US-11325937-B2 Glycoside compound and preparation method therefor, composition, application, and intermediate VEGFA, FLT4, FLT1 POLB 2684/4885CYP4A11 110/4885CYP4F2 1327/4885
US-20210115082-A1 GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE VEGFA, FLT4, FLT1 POLB 2684/4885CYP4A11 110/4885CYP4F2 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.